Don't miss this #CME / #AAPA podcast episode, "RSV Immunoprophylaxis: Maternal Vaccine vs Infant Antibody With Drs. Domachowske and @alisakachikis.bsky.social"
Available now on MedEd Talks: www.healio.com/cme/mededtal...
Available now on MedEd Talks: www.healio.com/cme/mededtal...
January 5, 2026 at 1:30 PM
Don't miss this #CME / #AAPA podcast episode, "RSV Immunoprophylaxis: Maternal Vaccine vs Infant Antibody With Drs. Domachowske and @alisakachikis.bsky.social"
Available now on MedEd Talks: www.healio.com/cme/mededtal...
Available now on MedEd Talks: www.healio.com/cme/mededtal...
The document evaluates maternal RSV vaccination during pregnancy and passive immunization of infants using long-acting monoclonal antibodies.
#Respiratory syncytial virus #Immunoprophylaxis
Details: doi.org/10.1007/s12519-025-00997-1
#Respiratory syncytial virus #Immunoprophylaxis
Details: doi.org/10.1007/s12519-025-00997-1
January 4, 2026 at 9:08 AM
The document evaluates maternal RSV vaccination during pregnancy and passive immunization of infants using long-acting monoclonal antibodies.
#Respiratory syncytial virus #Immunoprophylaxis
Details: doi.org/10.1007/s12519-025-00997-1
#Respiratory syncytial virus #Immunoprophylaxis
Details: doi.org/10.1007/s12519-025-00997-1
🔑 points include:
- HMPV is a major respiratory pathogen causing significant morbidity & mortality, esp in young children and older adults. Efforts to develop effective vaccines & immunoprophylaxis are ongoing.
- Promising vaccine approaches incl virus-like particles, live attenuated, epitope-based,
- HMPV is a major respiratory pathogen causing significant morbidity & mortality, esp in young children and older adults. Efforts to develop effective vaccines & immunoprophylaxis are ongoing.
- Promising vaccine approaches incl virus-like particles, live attenuated, epitope-based,
December 25, 2025 at 5:37 AM
🔑 points include:
- HMPV is a major respiratory pathogen causing significant morbidity & mortality, esp in young children and older adults. Efforts to develop effective vaccines & immunoprophylaxis are ongoing.
- Promising vaccine approaches incl virus-like particles, live attenuated, epitope-based,
- HMPV is a major respiratory pathogen causing significant morbidity & mortality, esp in young children and older adults. Efforts to develop effective vaccines & immunoprophylaxis are ongoing.
- Promising vaccine approaches incl virus-like particles, live attenuated, epitope-based,
In this #CME / #AAPA podcast episode, Drs. Kevin A. Ault and Alexis C. Gimovsky discuss effective interprofessional and patient communication strategies to address concerns about RSV immunoprophylaxis in pregnant women.
Find it here: www.healio.com/cme/mededtal...
Find it here: www.healio.com/cme/mededtal...
December 18, 2025 at 1:53 PM
In this #CME / #AAPA podcast episode, Drs. Kevin A. Ault and Alexis C. Gimovsky discuss effective interprofessional and patient communication strategies to address concerns about RSV immunoprophylaxis in pregnant women.
Find it here: www.healio.com/cme/mededtal...
Find it here: www.healio.com/cme/mededtal...
This study is the first to report #HBV #Genotype switching during MTCT, showing transmission despite maternal #Antiviral therapy & infant #Immunoprophylaxis, highlighting the role of #Quasispecies diversity in understanding MTCT.
#OpenAccess: doi.org/10.1016/j.dc...
#OpenAccess: doi.org/10.1016/j.dc...
December 16, 2025 at 1:24 PM
This study is the first to report #HBV #Genotype switching during MTCT, showing transmission despite maternal #Antiviral therapy & infant #Immunoprophylaxis, highlighting the role of #Quasispecies diversity in understanding MTCT.
#OpenAccess: doi.org/10.1016/j.dc...
#OpenAccess: doi.org/10.1016/j.dc...
Don't miss this #CME / #AAPA podcast episode, "RSV Immunoprophylaxis: Selecting the Best Prevention Option With Drs. Domachowske and Ault"
Available now on MedEd Talks: www.healio.com/cme/mededtal...
Available now on MedEd Talks: www.healio.com/cme/mededtal...
December 15, 2025 at 4:23 PM
Don't miss this #CME / #AAPA podcast episode, "RSV Immunoprophylaxis: Selecting the Best Prevention Option With Drs. Domachowske and Ault"
Available now on MedEd Talks: www.healio.com/cme/mededtal...
Available now on MedEd Talks: www.healio.com/cme/mededtal...
In this 4-part #CME / #AAPA podcast series, Drs. Kevin A. Ault and Joseph Domachowske are joined by expert faculty to discuss all things RSV immunoprophylaxis, from comprehension to counseling.
Find it here: www.healio.com/cme/mededtal...
Find it here: www.healio.com/cme/mededtal...
December 12, 2025 at 3:49 PM
In this 4-part #CME / #AAPA podcast series, Drs. Kevin A. Ault and Joseph Domachowske are joined by expert faculty to discuss all things RSV immunoprophylaxis, from comprehension to counseling.
Find it here: www.healio.com/cme/mededtal...
Find it here: www.healio.com/cme/mededtal...
In this #CME / #AAPA podcast episode, Drs. Joseph Domachowske and @alisakachikis.bsky.social discuss the available options for RSV immunoprophylaxis, their mechanisms, timing of administration, and clinical properties.
Find it here: www.healio.com/cme/mededtal...
Find it here: www.healio.com/cme/mededtal...
December 9, 2025 at 4:51 PM
In this #CME / #AAPA podcast episode, Drs. Joseph Domachowske and @alisakachikis.bsky.social discuss the available options for RSV immunoprophylaxis, their mechanisms, timing of administration, and clinical properties.
Find it here: www.healio.com/cme/mededtal...
Find it here: www.healio.com/cme/mededtal...
Don't miss this #CME / #AAPA podcast episode, "RSV Immunoprophylaxis: The Threat to Infants and Why Prevention Matters with Drs. Ault and Mejías"
Available now on MedEd Talks: www.healio.com/cme/mededtal...
Available now on MedEd Talks: www.healio.com/cme/mededtal...
December 4, 2025 at 7:44 PM
Don't miss this #CME / #AAPA podcast episode, "RSV Immunoprophylaxis: The Threat to Infants and Why Prevention Matters with Drs. Ault and Mejías"
Available now on MedEd Talks: www.healio.com/cme/mededtal...
Available now on MedEd Talks: www.healio.com/cme/mededtal...
The commonest cause in neonates is contracting it from the birth canal of an HBV positive mother, and the vaccine PREVENTS 90% OF ACUTE HBV INFECTIONS FROM BECOMING CHRONIC
Chronic HBV can lead to liver cirrhosis and hepatocellular carcinoma
Trump is going to cause a liver cancer epidemic
Chronic HBV can lead to liver cirrhosis and hepatocellular carcinoma
Trump is going to cause a liver cancer epidemic
![Causes
The most common cause of perinatal HBV infection is when a pregnant patient with
HBV infection gives birth and the infant does not receive postexposure immunoprophylaxis (hepatitis B birth dose and hepatitis B immune globulin [HBIG])
within 12 hours of birth [1].
An infant can also develop HBV infection through contact with blood or other bodily fluids from a person with HBV infection.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:t253pqf22arlgqwnmwy5xkns/bafkreidlvrhlicutdp45rxhhhjh3ob44i2k2g7smjunuo5hs2e5jpwjqsy@jpeg)
September 22, 2025 at 10:44 PM
The commonest cause in neonates is contracting it from the birth canal of an HBV positive mother, and the vaccine PREVENTS 90% OF ACUTE HBV INFECTIONS FROM BECOMING CHRONIC
Chronic HBV can lead to liver cirrhosis and hepatocellular carcinoma
Trump is going to cause a liver cancer epidemic
Chronic HBV can lead to liver cirrhosis and hepatocellular carcinoma
Trump is going to cause a liver cancer epidemic
Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Cat link.springer.com/article/10.1... #hvhebron #micro
Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infa...
To analyse the effect of nirsevimab immunoprophylaxis on RSV-associated outcomes after two consecutive epidemic seasons in infants born and Living in Catalonia, Spain. We conducted a population-based ...
link.springer.com
September 18, 2025 at 12:02 PM
Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Cat link.springer.com/article/10.1... #hvhebron #micro
3. this brought outrage from wider public and inquiries and statements regarding the pseudoscientific event from minister of social affairs, parliament members, joint statement from society of family doctors, immunoprophylaxis expert committee and Estonian Medical Association.
These were followed
These were followed
September 1, 2025 at 11:35 AM
3. this brought outrage from wider public and inquiries and statements regarding the pseudoscientific event from minister of social affairs, parliament members, joint statement from society of family doctors, immunoprophylaxis expert committee and Estonian Medical Association.
These were followed
These were followed
📢 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐞𝐝 𝐫𝐞𝐚𝐝𝐢𝐧𝐠
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
August 27, 2025 at 3:52 PM
📢 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐞𝐝 𝐫𝐞𝐚𝐝𝐢𝐧𝐠
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
" #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada"
Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3
#HEOR #Healtheconomics
“Children younger than 5 exhibited higher risk for hospital readmission after initial admission for RSV than after initial admission for influenza or human metapneumovirus, indicating the need for pediatric RSV immunoprophylaxis” www.infectiousdiseaseadvisor.com/news/hospita...
Hospital Readmission in Children More Likely After RSV Than After Influenza, hMPV
Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.
www.infectiousdiseaseadvisor.com
July 8, 2025 at 1:08 PM
“Children younger than 5 exhibited higher risk for hospital readmission after initial admission for RSV than after initial admission for influenza or human metapneumovirus, indicating the need for pediatric RSV immunoprophylaxis” www.infectiousdiseaseadvisor.com/news/hospita...
ICYMI: Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine
Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine
In order to evaluate and compare immunogenicity, reactogenicity and protection of a subunit vaccine and a whole virus vaccine 102 elderly subjects were vaccined against influenza in November 1986: 53 received the subunit vaccine and 49 were...
eurekamag.com
July 6, 2025 at 5:24 AM
ICYMI: Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine
Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine
Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine
In order to evaluate and compare immunogenicity, reactogenicity and protection of a subunit vaccine and a whole virus vaccine 102 elderly subjects were vaccined against influenza in November 1986: 53 received the subunit vaccine and 49 were...
eurekamag.com
July 5, 2025 at 5:23 AM
Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine
#Kyrgyzstan registers over 8,000 #measles cases
According to data from the Republican Center for Immunoprophylaxis of the Ministry of Health of the Kyrgyz Republic, as of June 17, 2025, 8,211 cases of measles were registered in the country,
According to data from the Republican Center for Immunoprophylaxis of the Ministry of Health of the Kyrgyz Republic, as of June 17, 2025, 8,211 cases of measles were registered in the country,
June 26, 2025 at 10:37 PM
#Kyrgyzstan registers over 8,000 #measles cases
According to data from the Republican Center for Immunoprophylaxis of the Ministry of Health of the Kyrgyz Republic, as of June 17, 2025, 8,211 cases of measles were registered in the country,
According to data from the Republican Center for Immunoprophylaxis of the Ministry of Health of the Kyrgyz Republic, as of June 17, 2025, 8,211 cases of measles were registered in the country,
Meissner is satisfied with the available data on the safety as is the RSV work group. Regarding concomitant administration with vaccines, there is no interference with vaccines on the schedule observed from administration of palivizumab, the previous generation passive immunoprophylaxis against...
June 26, 2025 at 12:43 PM
Meissner is satisfied with the available data on the safety as is the RSV work group. Regarding concomitant administration with vaccines, there is no interference with vaccines on the schedule observed from administration of palivizumab, the previous generation passive immunoprophylaxis against...
Vectored immunoprophylaxis for HIV.
Talk by @billgates.com foundation mentioning a great start-up called Addition Therapeutics!
#asgct2025
Talk by @billgates.com foundation mentioning a great start-up called Addition Therapeutics!
#asgct2025
May 14, 2025 at 4:13 PM
Vectored immunoprophylaxis for HIV.
Talk by @billgates.com foundation mentioning a great start-up called Addition Therapeutics!
#asgct2025
Talk by @billgates.com foundation mentioning a great start-up called Addition Therapeutics!
#asgct2025
Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-related Outcomes in Hospital Care… journals.lww.com/pidj/abstrac... #hvhebron #upiip
Effectiveness of Nirsevimab Immunoprophylaxis Against... : The Pediatric Infectious Disease Journal
ber to January 2024) and compared them with the catch-up cohort (born from April to September 2023).
Methods:
Retrospective cohort study of all infants born between October 1, 2023, and January 21,...
journals.lww.com
April 17, 2025 at 3:42 PM
Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-related Outcomes in Hospital Care… journals.lww.com/pidj/abstrac... #hvhebron #upiip
We invite you to join fellow PIDS members at a special breakfast symposium at PAS sponsored by Sanofi. RSV Immunoprophylaxis is Sat. 4/26 at 5:45am HT. Registration available on our PAS meetings page. #IDsky #PAS2025
pids.org/event/pas-20...
pids.org/event/pas-20...
April 15, 2025 at 2:18 PM
We invite you to join fellow PIDS members at a special breakfast symposium at PAS sponsored by Sanofi. RSV Immunoprophylaxis is Sat. 4/26 at 5:45am HT. Registration available on our PAS meetings page. #IDsky #PAS2025
pids.org/event/pas-20...
pids.org/event/pas-20...
1. Increase water intake ✔️
2. Vaginal oestrogen ✔️
3. Immunoprophylaxis ✔️
4. D-mannose (data mixed) 🤔
5. Probiotics (heterogeneity++)❓️
6. Methenamine ✔️
7. Intra-vesical GAGs & abx (small studies only)❓️--> look out for VESPER trial now ongoing in the UK 👍🏼
2. Vaginal oestrogen ✔️
3. Immunoprophylaxis ✔️
4. D-mannose (data mixed) 🤔
5. Probiotics (heterogeneity++)❓️
6. Methenamine ✔️
7. Intra-vesical GAGs & abx (small studies only)❓️--> look out for VESPER trial now ongoing in the UK 👍🏼
April 12, 2025 at 8:12 AM
1. Increase water intake ✔️
2. Vaginal oestrogen ✔️
3. Immunoprophylaxis ✔️
4. D-mannose (data mixed) 🤔
5. Probiotics (heterogeneity++)❓️
6. Methenamine ✔️
7. Intra-vesical GAGs & abx (small studies only)❓️--> look out for VESPER trial now ongoing in the UK 👍🏼
2. Vaginal oestrogen ✔️
3. Immunoprophylaxis ✔️
4. D-mannose (data mixed) 🤔
5. Probiotics (heterogeneity++)❓️
6. Methenamine ✔️
7. Intra-vesical GAGs & abx (small studies only)❓️--> look out for VESPER trial now ongoing in the UK 👍🏼
📖 Study of the pathogenesis of caprine tuberculosis and paratuberculosis. Control by means of immunoprophylaxis with inactivated mycobacteria and their immunoprotein derivatives. 🐐
March 25, 2025 at 10:08 PM
📖 Study of the pathogenesis of caprine tuberculosis and paratuberculosis. Control by means of immunoprophylaxis with inactivated mycobacteria and their immunoprotein derivatives. 🐐
RSV prevention - new vaccines for pregnant women and immunoprophylaxis of infants now available
Commentary by @theurichconsult.bsky.social in #IntBreastfeedJ reminds everyone to promote breastfeeding as an additional preventive and treatment strategy
tinyurl.com/4e4dc2nk
Commentary by @theurichconsult.bsky.social in #IntBreastfeedJ reminds everyone to promote breastfeeding as an additional preventive and treatment strategy
tinyurl.com/4e4dc2nk
March 4, 2025 at 10:26 PM
RSV prevention - new vaccines for pregnant women and immunoprophylaxis of infants now available
Commentary by @theurichconsult.bsky.social in #IntBreastfeedJ reminds everyone to promote breastfeeding as an additional preventive and treatment strategy
tinyurl.com/4e4dc2nk
Commentary by @theurichconsult.bsky.social in #IntBreastfeedJ reminds everyone to promote breastfeeding as an additional preventive and treatment strategy
tinyurl.com/4e4dc2nk
Join us Wed., March 12 for breakfast at #NAPNAPConf!
"Pediatric RSV Prevention: Critical Insights for the Nurse Practitioner" will equip you with the latest insights on pediatric RSV immunoprophylaxis!
Register today to join us IN-PERSON >> ow.ly/BmBG50UVFiX
@patsykene.bsky.social
"Pediatric RSV Prevention: Critical Insights for the Nurse Practitioner" will equip you with the latest insights on pediatric RSV immunoprophylaxis!
Register today to join us IN-PERSON >> ow.ly/BmBG50UVFiX
@patsykene.bsky.social
February 13, 2025 at 3:04 PM
Join us Wed., March 12 for breakfast at #NAPNAPConf!
"Pediatric RSV Prevention: Critical Insights for the Nurse Practitioner" will equip you with the latest insights on pediatric RSV immunoprophylaxis!
Register today to join us IN-PERSON >> ow.ly/BmBG50UVFiX
@patsykene.bsky.social
"Pediatric RSV Prevention: Critical Insights for the Nurse Practitioner" will equip you with the latest insights on pediatric RSV immunoprophylaxis!
Register today to join us IN-PERSON >> ow.ly/BmBG50UVFiX
@patsykene.bsky.social